79 related articles for article (PubMed ID: 2517634)
1. Apolipoproteins A-I and B in non-insulin-dependent diabetes mellitus.
Lee LS; Hwang JY; Chang JJ; Hsu CH; Liao ST; Lo IL
Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1139-42. PubMed ID: 2517634
[TBL] [Abstract][Full Text] [Related]
2. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
3. [Serum lipids and apolipoproteins AI, B100, CI and CII in noninsulin-dependent diabetics].
Liu BW; Liang JS; Fu MD
Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):627-9, 653-4. PubMed ID: 3147855
[No Abstract] [Full Text] [Related]
4. [Serum apolipoprotein and lipoprotein levels in patients with diabetes mellitus type 2].
Gosiewska A; Zarzycki W; Depta K; Składanek J; Kinalski M; Lopaczyński W
Wiad Lek; 1989 Apr; 42(7):436-40. PubMed ID: 2629300
[TBL] [Abstract][Full Text] [Related]
5. [Effects of different types of treatment on serum HDL-C apoA I and apoB100 in non-insulin dependent diabetes mellitus].
Li Y; Liang JZ; Zhang XX
Hua Xi Yi Ke Da Xue Xue Bao; 1988 Mar; 19(1):5-8. PubMed ID: 3134288
[No Abstract] [Full Text] [Related]
6. Apolipoprotein levels in normolipidemic non-insulin-dependent diabetes mellitus.
Horng YC; Wei JS; Chang RS; Huang HS; Huang MJ; Huang BY
J Formos Med Assoc; 1992 Jun; 91(6):590-4. PubMed ID: 1358344
[TBL] [Abstract][Full Text] [Related]
7. Analysis of serum apolipoprotein A-I in elderly non-insulin-dependent diabetic patients.
Folin M; Contiero E; Ferrari R; Vaselli GM
Diabetes Res; 1994; 26(4):155-71. PubMed ID: 7648790
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
[TBL] [Abstract][Full Text] [Related]
9. Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.
Saito M; Eto M; Okada M; Iwashima Y; Makino I
Artery; 1996; 22(3):155-63. PubMed ID: 8893973
[TBL] [Abstract][Full Text] [Related]
10. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
11. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.
Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD
J Clin Endocrinol Metab; 1987 Sep; 65(3):512-8. PubMed ID: 3114304
[TBL] [Abstract][Full Text] [Related]
12. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
13. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus.
Fuh MM; Shieh SM
Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416
[TBL] [Abstract][Full Text] [Related]
14. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.
Billingham MS; Milles JJ; Green A; Bailey CJ; Hall RA
Scand J Clin Lab Invest; 1989 May; 49(3):239-47. PubMed ID: 2500699
[TBL] [Abstract][Full Text] [Related]
16. [Serum apolipoprotein AI, B levels in patients with coronary diseases].
He Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Aug; 18(4):217-9, 254. PubMed ID: 2128269
[TBL] [Abstract][Full Text] [Related]
17. Apolipoproteins AI and B and plasma lipid values in well-treated diabetic patients from Romania.
Dabelea D; Serban V; Băcanu G; Deutsch G; Pataki C; Dan I
Rom J Intern Med; 1995; 33(3-4):249-56. PubMed ID: 8646198
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) concentrations in type 2 (non-insulin dependent) diabetic patients from Romania.
Dabelea D; Serban V; Băcanu GS; Deutsch G; Dan I
Rom J Intern Med; 1995; 33(1-2):85-92. PubMed ID: 8535357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
